Literature DB >> 8291602

Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver.

M L Liu1, W M Mars, R Zarnegar, G K Michalopoulos.   

Abstract

We have previously shown that systemically injected hepatocyte growth factor (HGF) is primarily taken up by the liver. The present study shows that HGF injected systemically or through the portal circulation is retained primarily at periportal sites. The periportal retention of HGF seems to persist longer in regenerating liver. The percentage of the total HGF injected that was retained within the liver at 1 minute after injection varied with the dose. A maximal amount of 0.157 +/- 0.012 microgram of HGF per gram liver tissue is retained by normal liver. Analysis of the circulating form of HGF in the plasma showed a relative enrichment with time for the heterodimeric form of HGF. A portion of portally injected HGF, composed of both single chain and two chain (heterodimeric) form was excreted intact in the bile. This was found in both normal and regenerating liver. These studies show that the liver can sequester large amounts of HGF and that the sequestration occurs primarily at periportal sites. Our studies support the hypothesis that a nonlysosomal processing pathway for HGF is present in the liver.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8291602      PMCID: PMC1887116     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  Promyelocytic leukemia cell line, HL-60, produces human hepatocyte growth factor.

Authors:  T Nishino; N Kaise; Y Sindo; N Nishino; T Nishida; S Yasuda; Y Masui
Journal:  Biochem Biophys Res Commun       Date:  1991-11-27       Impact factor: 3.575

2.  Evidence for a vesicular transport mechanism in hepatocytes for biliary secretion of immunoglobulin A.

Authors:  R H Renston; A L Jones; W D Christiansen; G T Hradek; B J Underdown
Journal:  Science       Date:  1980-06-13       Impact factor: 47.728

3.  Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines.

Authors:  H Tajima; K Matsumoto; T Nakamura
Journal:  FEBS Lett       Date:  1991-10-21       Impact factor: 4.124

4.  Significance of serum human hepatocyte growth factor levels in patients with hepatic failure.

Authors:  T Tomiya; S Nagoshi; K Fujiwara
Journal:  Hepatology       Date:  1992-01       Impact factor: 17.425

5.  Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells.

Authors:  P Schirmacher; A Geerts; A Pietrangelo; H P Dienes; C E Rogler
Journal:  Hepatology       Date:  1992-01       Impact factor: 17.425

6.  Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells.

Authors:  G Shiota; D B Rhoads; T C Wang; T Nakamura; E V Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

7.  Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy.

Authors:  R Zarnegar; M C DeFrances; D P Kost; P Lindroos; G K Michalopoulos
Journal:  Biochem Biophys Res Commun       Date:  1991-05-31       Impact factor: 3.575

8.  Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration.

Authors:  P M Lindroos; R Zarnegar; G K Michalopoulos
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

9.  Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study.

Authors:  H K Wolf; R Zarnegar; G K Michalopoulos
Journal:  Hepatology       Date:  1991-09       Impact factor: 17.425

10.  Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor.

Authors:  R Montesano; K Matsumoto; T Nakamura; L Orci
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

View more
  19 in total

1.  The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat.

Authors:  P Pediaditakis; J C Lopez-Talavera; B Petersen; S P Monga; G K Michalopoulos
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

2.  Immunohistochemical study of hepatic oval cells in human chronic viral hepatitis.

Authors:  X Ma; D K Qiu; Y S Peng
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 3.  Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas.

Authors:  George K Michalopoulos
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

4.  Alterations in the rat serum proteome during liver injury from acetaminophen exposure.

Authors:  B Alex Merrick; Maribel E Bruno; Jennifer H Madenspacher; Barbara A Wetmore; Julie Foley; Rembert Pieper; Ming Zhao; Anthony J Makusky; Andrew M McGrath; Jeff X Zhou; John Taylor; Kenneth B Tomer
Journal:  J Pharmacol Exp Ther       Date:  2006-05-10       Impact factor: 4.030

Review 5.  The useful agent to have an ideal biological scaffold.

Authors:  Raziyeh Kheirjou; Jafar Soleimani Rad; Ahad Ferdowsi Khosroshahi; Leila Roshangar
Journal:  Cell Tissue Bank       Date:  2020-11-22       Impact factor: 1.522

Review 6.  Liver regeneration: biological and pathological mechanisms and implications.

Authors:  George K Michalopoulos; Bharat Bhushan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-06       Impact factor: 46.802

7.  Proliferation induced by keratinocyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytes.

Authors:  A Bosch; P B McCray; S M Chang; T R Ulich; W S Simonet; D J Jolly; B L Davidson
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

8.  Liver regeneration and the atrophy-hypertrophy complex.

Authors:  Robin D Kim; Jae Sung Kim; Go Watanabe; Dagmara Mohuczy; Kevin E Behrns
Journal:  Semin Intervent Radiol       Date:  2008-06       Impact factor: 1.513

9.  Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy.

Authors:  Senda Ajroud-Driss; Mark Christiansen; Jeffrey A Allen; John A Kessler
Journal:  Mol Ther       Date:  2013-04-23       Impact factor: 11.454

10.  Controlled release of hepatocyte growth factor from a bovine acellular scaffold for vocal fold reconstruction.

Authors:  Chet C Xu; Roger W Chan; Debra G Weinberger; Guy Efune; Karen S Pawlowski
Journal:  J Biomed Mater Res A       Date:  2010-06-15       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.